Prostaglandin F2α: A bone remodeling mediator

Journal of Cellular Physiology

Volumn 228, Issue 1, 2013, Pages 25-29

  Agas, Dimitrios ^a   Marchetti, Luigi ^a   Hurley, Marja M ^b   Sabbieti, Maria Giovanna ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; HEAT SHOCK PROTEIN 27; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PROSTAGLANDIN F2 ALPHA; PROTEIN KINASE C; SODIUM; STRESS ACTIVATED PROTEIN KINASE; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; BONE DISEASE; BONE METABOLISM; BONE MINERALIZATION; BONE REMODELING; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CYTOKINE PRODUCTION; FRACTURE HEALING; METABOLIC REGULATION; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; BONE AND BONES; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; DINOPROST; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; INTERLEUKIN-6; OSTEOBLASTS; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84867188347     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24117     Document Type: Review

References (85)

1. Agas D, Marchetti L, Menghi G, Materazzi S, Materazzi G, Capacchietti M, Hurley MM, Sabbieti MG. 2008. Anti-apoptotic Bcl-2 enhancing requires FGF-2/FGF receptor 1 binding in mouse osteoblasts. J Cell Physiol 214: 145-152.
2. Alao JP. 2007. The regulation of cyclin D1 degradation: Roles in cancer development and the potential for therapeutic invention. Mol Cancer 6: 24.
3. Beck GR, Jr. 2003. Inorganic phosphate as a signaling molecule in osteoblast differentiation. J Cell Biochem 90: 234-243.
4. Beck GR, Jr., Knecht N. 2003. Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent. J Biol Chem 278: 41921-41929.
5. Beck GR, Jr., Zerler B, Moran E. 2000. Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci USA 97: 8352-8357.
6. Blackwell KA, Raisz LG, Pilbeam CC. 2010. Prostaglandins in bone: Bad cop, good cop? Trends Endocrinol Metab 21: 294-301.
7. Canalis E, Rydziel S. 2002. Platelet-derived growth factor and the skeleton. Princ Bone Biol 2: 817-824.
8. Caverzasio J, Montessuit C, Bonjour JP. 1996. Functional role of Pi transport in osteogenic cells. News Physiol Sci 11: 119-125.
9. Caverzasio J, Palmer G, Suzuki A, Bonjour JP. 2000. Evidence for the involvement of two pathways in activation of extracellular signal-regulated kinase (Erk) and cell proliferation by Gi and Gq protein-coupled receptors in osteoblast-like cells. J Bone Miner Res 15: 1697-1706.
10. Cho TJ, Gerstenfeld LC, Barnes GL, Einhorn TA. 2001. Cytokines and fracture healing. Curr Opin Orthop 12: 403-408.
11. Cory S, Adams JM. 2002. The Bcl2 family: Regulators of the cellular life- or death switch. Nat Rev Cancer 2: 647-656.
12. Erlebacher A, Filvaroff EH, Girelman SE, Derynck R. 1995. Toward a molecular understanding of skeletal development. Cell 80: 371-378.
13. Fall PM, Breault DT, Raisz LG. 1994. Inhibition of collagen synthesis by prostaglandins in the immortalized rat osteoblasticclonal cell line Py1a: Structure activity relations and signal transduction mechanism. J Bone Miner Res 9: 1935-1943.
14. Ferrara N, Davis-Smyth T. 1997. The biology of vascular endothelial growth factor. Endocr Rev 18: 4-25.
15. Feyen JHM, Elford P, Di Padonova FE, Trechsel U. 1989. Interleukin-6 is produced by bone and modulated by parathyroid hormone. J Bone Miner Res 4: 633-638.
16. Florkiewicz RZ, Baird A, Gonzalez AM. 1991. Multiple forms of bFGF: Differential nuclear and cell surface localization. Growth Factors 4: 265-275.
17. Gerber H-P, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5: 623-628.
18. Globus RK, Plouet J, Gospodarowicz D. 1989. Cultured bovine bone cells synthesize basic fibroblast growth factor and store it in their extracellular matrix. Endocrinology 124: 1539-1547.
19. Hakeda Y, Hotta T, Kurihara N, Ikeda E, Maeda N, Yagyu Y, Kumegawa M. 1987. Prostaglandin E1 and F2α stimulate differentiation and proliferation respectively of clonal osteoblastic MC3T3-E1 cells by different second messengers in vitro. Endocrinology 121: 1966-1973.
20. Hakeda Y, Shiokawa M, Mano H, Kameda T, Raisz LG, Kumegawa M. 1997. Prostaglandin F2α stimulates tyrosine phosphorylation and mitogen-activated protein kinase in osteoblastic MC3T3-E1 cells via protein kinase C activation. Endocrinology 138: 1821-1828.
21. Hanai Y, Tokuda H, Ohta T, Matsushima-Nishiwaki R, Takai S, Kozawa O. 2006. Phosphatidylinositol 3-kinase/Akt autoregulates PDGF-BB-stimulated interleukin-6 synthesis in osteoblasts. J Cell Biochem 99: 1564-1571.
22. Harmey D, Stenbeck G, Nobes CD, Lax AJ, Grigoriadis AE. 2004. Regulation of osteoblast differentiation by Pasteurellamultocida toxin (PMT): A role for Rho GTPase in bone formation. J Bone Miner Res 19: 661-670.
23. Heldin CH, Westermark B. 1999. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316.
24. Heymann D, Rousselle AV. 2000. gp130 Cytokine family and bone cells. Cytokine 12: 1455-1468.
25. Hill PA. 1998. Bone remodelling. Br J Orthod 25: 101-107.
26. Hosokawa Y, Arnold A. 1996. Cyclin D1/PRAD1 as a central target in oncogenesis. J Lab Clin Med 127: 246-252.
27. Hughes FJ, Howells GL. 1993. Interleukin-6 inhibits bone formation in vitro. Bone Miner 21: 21-28.
28. Hurley MM, Florkiewicz R. 1996. Fibroblas growth factor and vascular endothelial fibroblast growth factor families. In: Belizikian J, Raisz LG, Rodan G, editors. Principles of bone biology. San Diego, CA, USA: Academic Press. pp 627-645.
29. Hurley MM, Okada Y, Xiao L, Tanaka Y, Ito M, Okimoto N, Nakamura T, Rosen CJ, Doetschaman T, Coffin JD. 2006. Impaired bone anabolic response to parathyroid hormone in Fgf2-/- and Fgf2+/- mice. Biochem Biophys Res Commun 341: 989-994.
30. Jimi E, Nakamura I, Amano H, Taguchi Y, Tsurukai T, Tamura M, Takahashi N, Suda T. 1996. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology 137: 2187-2190.
31. Kamon M, Fujita D, Goto N, Amano H, Sakamoto K. 2008. Prostaglandin F(2alpha) negatively regulates bone resorption in murine osteoclast development. Prostaglandins Other Lipid Mediat 87: 26-33.
32. Karlsson A, Deb-Basu D, Cherry A, Turner S, Ford J, Felsher DW. 2003. Defective doublestrand DNA break repair and chromosomal translocations by MYC overexpression. Proc Natl Acad Sci USA 100: 9974-9979.
33. Kavanaugh MP, Miller DG, Zhang W, Law W, Kozak SL, Kabat D, Miller AD. 1994. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 91: 7071-7075.
34. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103: 1345-1352.
35. Kozawa O, Suzuki A, Tokuda H, Uematsu T. 1997. Prostaglandin F2α stimulates interleukin-6 synthesis via activation of PKC in osteoblast-like cells. Am J Physiol 272: E208-E211.
36. Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y. 2004. IL-6, RANKL, TNF-α/IL-1: Interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 15: 49-60.
37. Lai CF, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, Cheng SL. 2001. Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 276: 14443-14450.
38. Marchetti L, Sabbieti MG, Agas D, Menghi M, Materazzi G, Menghi G, Hurley MM. 2006. PGF2α increases FGF-2 and FGFR2 trafficking in Py1a rat osteoblasts via clathrin independent and importin β dependent pathway. J Cell Biochem 97: 1379-1392.
39. Marie PJ. 2003. Fibroblast growth factor signalling controlling osteoblast differentiation. Gene 316: 23-32.
40. Matsuo K, Irie N. 2008. Osteoclast-osteoblast communication. Arch Biochem Biophys 473: 201-209.
41. Minamitani C, Otsuka T, Takai S, Matsushima-Nishiwaki R, Adachi S, Hanai Y, Mizutani J, Tokuda H, Kozawa O. 2008. Involvement of Rho-kinase in prostaglandin F2alpha-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts. Mol Cell Endocrinol 291: 27-32.
42. Montessuit C, Caverzasio J, Bonjour JP. 1991. Characterization of a Pi transport system in cartilage matrix vesicles. J Biol Chem 256: 1791-1797.
43. Montessuit C, Bonjour JP, Caverzasio J. 1995. Expression and regulation of Na-dependent Pi transport in matrix vesicles produced by osteoblast-like cells. J Bone Miner Res 10: 625-631.
44. Naganawa T, Xiao L, Abogunde E, Sobue T, Kalajzic I, Sabbieti M, Agas D, Hurley MM. 2006. In vivo and in vitro comparison of the effects of FGF-2 null and haplo-insufficiency on bone formation in mice. Biochem Biophys Res Commun 339: 490-498.
45. Nagata T, Kaho K, Nishikawa S, Shindrara H, Wakano Y, Ishida H. 1994. Effect of prostaglandin E2 on mineralization of bone nodules formed by fetal rat calvarial cells. Calcif Tissue Int 55: 451-457.
46. Nielsen LB, Pedersen FS, Pedersen L. 2001. Expression of type III sodium-dependent phosphate transporters/retroviral receptors mRNAs during osteoblast differentiation. Bone 28: 160-166.
47. Nijweide PJ, Burger EH, Feyen JHM. 1986. Cells of bone: Proliferation, differentiation and hormonal regulation. Physiol Rev 66: 855-886.
48. Nishizuka Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614.
49. Partanen J, Vainikka S, Alitalo K. 1993. Structural and functional specificity of FGF receptors. Philos Trans R Soc Lond B Biol Sci 340: 297-303.
50. Pilbeam CC, Harrison JR, Raisz LG. 1996. Prostaglandins and bone metabolism. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. San Diego: Academic Press. pp 715-728.
51. Quarles CD, Haupt DM, Davidai G, Middleton JP. 1993. Prostaglandin F2α induced mitogenesis in MC3T3-E1 osteoblasts: Role of protein kinase-C-mediated tyrosine phosphorylation. Endocrinology 132: 1505-1513.
52. Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD. 1994. Programmed cell death and the control of cell survival. Philos Trans Soc Lond Biol Sci 30: 265-268.
53. Raisz LG, Fall PM. 1990. Biphasic effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: Interaction with cortisol. Endocrinology 126: 1654-1659.
54. Raisz LG, Koolemans-Beynen AR. 1974. Inhibition of bone collagen synthesis by prostaglandin E2 in organ culture. Prostaglandins 8: 377-385.
55. Raisz LG, Martin TJ. 1984. Prostaglandins in bone and mineral metabolism. In: Peck WA, editor. Bone and mineral research. Volume 2. Amsterdam: Elsevier. pp 286-310.
56. Raisz LG, Fall PM, Petersen DN, Lichtler A, Kream BE. 1993. Prostaglandin E2 inhibits α1 (I) procollagen gene transcription and promoter activity in the immortalized rat osteoblastic clonal cell line Py1a. Mol Endocrinol 7: 17-22.
57. Reilly JF, Maher PA. 2001. Importin b-mediated nuclear import of fibroblast growth factor receptor: Role in cell proliferation. J Cell Biol 152: 1307-1312.
58. Rodman GD. 1992. Interleukin-6: An osteotropic factor? J Bone Miner Res 7: 475-478.
59. Sabbieti MG, Marchetti L, Abreu C, Montero A, Hand AR, Raisz LG, Hurley MM. 1999. Prostaglandins regulate the expression of fibroblast growth factor-2 in bone. Endocrinology 140: 434-444.
60. Sabbieti MG, Marchetti L, Gabrielli MG, Menghi M, Materazzi S, Menghi G, Raisz LG, Hurley MM. 2005. Prostaglandins differently regulate FGF-2 and FGF receptor expression and induce nuclear translocation in osteoblasts via MAP kinase. Cell Tissue Res 319: 267-278.
61. Sabbieti MG, Agas D, Materazzi S, Capacchietti M, Materazzi G, Hurley MM, Menghi G, Marchetti L. 2008. Prostaglandin F2alpha involves heparan sulphate sugar chains and FGFRs to modulate osteoblast growth and differentiation. J Cell Physiol 217: 48-59.
62. Sabbieti MG, Agas D, Marchetti L, Santoni G, Amantini C, Xiao L, Menghi G, Hurley MM. 2010. Signaling pathways implicated in PGF2alpha effects on Fgf2+/+ and Fgf2-/- osteoblasts. J Cell Physiol 224: 465-474.
63. Sato I, Suzuki A, Kakita A, Ono Y, Miura Y, Itoh M, Oiso Y. 2003. Stimulatory effect of prostaglandin F2α on Na-dependent phosphate transport in osteoblast-like cells. Prostagladins Leukot Essent Fatty Acids 68: 311-315.
64. Schalaeppi JM, Gutzwiller S, Finlenzeller G, Fournier B. 1997. 1, 25-Dihydroxyvitamin D3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocr Res 23: 213-229.
65. Scutt A, Zeschnigk M, Bertram P. 1995. PGE2 induces the transition from nonadherent to adherent bone marrow mesenchymal precursor cells via a cAMP/EP2-mediated mechanism. Prostaglandins 49: 383-395.
66. Stachowiak MK, Maher PA, Joy A, Mordechai E, Stachowiak EK. 1996. Nuclear accumulation of fibroblast growth factor receptors is regulated by multiple signals in adrenal medullary cells. Mol Biol Cell 7: 1299-1317.
67. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. 1999. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20: 345-357.
68. Suzuki A, Itoh M. 2006. Proliferation differentiation and mineralization of osteoblasts by prostaglandins. In: Bronson CS, editor. Prostaglandins: New research. New York, USA: Nova Sciences Publishers, Inc. pp 91-106.
69. Thompson CB. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462.
70. Tokuda H, Kozawa O, Harada A, Uematsu T. 1999. p42/p44 Mitogenactivated protein kinase activation is involved in prostaglandin F2 α-induced interleukin-6 synthesis in osteoblasts. Cell Signal 11: 325-330.
71. Tokuda H, Kozawa O, Uematsu T. 2002. Interleukin (IL)-17 enhances prostaglandin F(2 alpha)-stimulated IL-6 synthesis in osteoblasts. Prostaglandins Leukot Essent Fatty Acids 66: 427-433.
72. Tokuda H, Harada A, Hirade K, Matsuno H, Ito H, Kato K, Oiso Y, Kozawa O. 2003. Incadronate amplifies prostaglandin F2α induced vascular endothelial growth factor in osteoblasts: Enhancement of MAP kinase activity. J Biol Chem 278: 18930-18937.
73. Tokuda H, Niwa M, Ishisaki A, Nakajima K, Ito H, Kato K, Kozawa O. 2004. Involvement of stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK) in prostaglandin F2alpha induced heat shock protein 27 in osteoblasts. Prostaglandins Leukot Essent Fatty Acids 70: 441-447.
74. Tokuda H, Takai S, Hanai Y, Harada A, Matsushima-Nishiwaki R, Akamatsu S, Ohta T, Kozawa O. 2007. Platelet-derived growth factor-B amplifies PGF2alpha-stimulated VEGF synthesis in osteoblasts: Function of phosphatidylinositol 3-kinase. Prostaglandins Leukot Essent Fatty Acids 77: 187-193.
75. Urade Y, Hayaishi O. 2000. Prostaglandin D synthase: Structure and function. Vitam Horm 58: 89-120.
76. Vaux DL, Cory S, Adams JM. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442.
77. Wagstaff MJ, Collaço-Moraes Y, Smith J, de Belleroche JS, Coffin RS, Latchman DS. 1999. Protection of neuronal cells from apoptosis by Hsp27 delivered with a herpes simplex virus-based vector. J Biol Chem 274: 5061-5069.
78. Wang D, DuBois RN. 2006. Prostaglandins and cancer. Gut 55: 115-122.
79. Wang DS, Yamazaki K, Nohtomi K, Shizume K, Ohsumi K, Shibuya M, Demura H, Sato K. 1996. Increase of vascular endothelial growth factor mRNA expression by 1, 25-dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res 11: 472-479.
80. Windischhofer W, Zach D, Fauler G, Raspotnig G, Kofeler H, Leis HJ. 2002. Involvement of Rho and p38MAPK in endothelin-1-induced expression of PGHS-2 mRNA in osteoblast-like cells. J Bone Miner Res 17: 1774-1784.
81. Woodiel FN, Fall PM, Raisz LG. 1996. Anabolic effects of prostaglandins in cultured fetal rat calvariae: Structure-activity relations and signal transduction pathway. J Bone Miner Res 11: 1249-1255.
82. Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, Fujita N, Morita K, Ninomiya K, Suzuki T, Miyamoto K, Oike Y, Takeya M, Toyama Y, Suda T. 2005. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202: 345-351.
83. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. 1998. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95: 3597-3602.
84. Yoshiko Y, Candeliere GA, Maeda N, Aubin JE. 2007. Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization. Mol Cell Biol 27: 44-65.
85. Zoidis E, Ghirlanda-Keller C, Gosteli-Peter M, Zapf J, Schmid C. 2004. Regulation of phosphate (Pi) transport and NaPi-III transporter (Pit-1) mRNA in rat osteoblasts. J Endocrinol 181: 531-540.